Literature DB >> 11878512

Therapeutic activity of NK cells against tumors.

P H Basse, T L Whiteside, W Chambers, R B Herberman.   

Abstract

While it is generally accepted that natural killer (NK) cells, by killing tumor cells in the circulation, represent a first line of defense against metastases, their therapeutic activity against established tumors has been limited. In this review, we describe studies to improve the therapeutic effectiveness of activated NK cells in both animal models and clinical trials to better understand the biological problems that limit their effectiveness.

Entities:  

Mesh：

Year:  2001        PMID： 11878512     DOI： 10.3109/08830180109054416

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN： 0883-0185            Impact factor:   5.311


  9 in total

Review 1.  The role of vitamin D in hepatic metastases from colorectal cancer.

Authors:  E Shaw; N Massaro; N T Brockton
Journal:  Clin Transl Oncol       Date:  2017-08-11       Impact factor: 3.405

2.  Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.

Authors:  Jeffrey L Wong; Robbie B Mailliard; Stergios J Moschos; Howard Edington; Michael T Lotze; John M Kirkwood; Pawel Kalinski
Journal:  J Immunother       Date:  2011-04       Impact factor: 4.456

3.  Arrest of B16 melanoma cells in the mouse pulmonary microcirculation induces endothelial nitric oxide synthase-dependent nitric oxide release that is cytotoxic to the tumor cells.

Authors:  Hongming Qiu; F William Orr; Derrek Jensen; Hui Helen Wang; Alan R McIntosh; Brian B Hasinoff; Dwight M Nance; Susan Pylypas; Ke Qi; Chun Song; Ruth J Muschel; Abu-Bakr Al-Mehdi
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

4.  Rat colon carcinoma cells that survived systemic immune surveillance are less sensitive to NK-cell mediated apoptosis.

Authors:  Jurjen H L Velthuis; Miranda Stitzinger; Remco I J M Aalbers; Hans J G M de Bont; Gerard J Mulder; Peter J K Kuppen; J Fred Nagelkerke
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 5.  Clinical grade purification and expansion of natural killer cells.

Authors:  Natalia Lapteva; Susann M Szmania; Frits van Rhee; Cliona M Rooney
Journal:  Crit Rev Oncog       Date:  2014

Review 6.  Brain Tumor Immunotherapy: What have We Learned so Far?

Authors:  Stefaan Willy Van Gool
Journal:  Front Oncol       Date:  2015-06-17       Impact factor: 6.244

7.  Gamma delta T cells provide an early source of interferon gamma in tumor immunity.

Authors:  Yunfei Gao; Wancai Yang; Meng Pan; Eileen Scully; Michael Girardi; Leonard H Augenlicht; Joe Craft; Zhinan Yin
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

8.  KIR Genes and Patterns Given by the A Priori Algorithm: Immunity for Haematological Malignancies.

Authors:  J Gilberto Rodríguez-Escobedo; Christian A García-Sepúlveda; Juan C Cuevas-Tello
Journal:  Comput Math Methods Med       Date:  2015-09-30       Impact factor: 2.238

9.  Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2.

Authors:  Xiao Tian; Feng Wei; Limei Wang; Wenwen Yu; Naining Zhang; Xinwei Zhang; Ying Han; Jinpu Yu; Xiubao Ren
Journal:  Front Immunol       Date:  2017-10-30       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.